"The National Heart Centre Singapore (NHCS) is a national and regional referral centre for cardiovascular diseases. NHCS provides a one-stop comprehensive cardiac care ranging from preventive, diagnostic, therapeutic to rehabilitative services. Established in 1998, NHCS is the pioneer in cardiovascular care in Singapore. It is also the only heart and lung transplantation centre in Singapore. Its clinical outcomes for heart attack treatment, balloon angioplasty with stenting and coronary bypass surgery have been shown to be equivalent to international benchmarks."

During the past decade, National Heart Centre Singapore conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 26 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 17 clinical trials were completed. i.e. 65.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Heart Centre Singapore" #1 sponsor was "National Heart Centre Singapore" with 40 trials, followed by "Boston Scientific Corporation" with 14 trials sponsored, "Actelion" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Biotronik SE & Co. KG" with 6 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Heart Centre Singapore" #1 collaborator was "National Heart Centre Singapore" with 7 trials as a collaborator, "Singapore General Hospital" with 6 trials as a collaborator, "Changi General Hospital" with 5 trials as a collaborator, "National University Hospital, Singapore" with 5 trials as a collaborator and "Duke-NUS Graduate Medical School" with 3 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "National Heart Centre Singapore" are "Coronary Artery Disease" (22 trials), "Heart Failure" (13 trials), "Pulmonary Arterial Hypertension" (10 trials), "Atrial Fibrillation" (9 trials) and "Hypertension" (7 trials). Many other conditions were trialed in "National Heart Centre Singapore" in a lesser frequency.

Most popular intervention types in "National Heart Centre Singapore" are "Device" (32 trials), "Other" (29 trials), "Drug" (28 trials), "Procedure" (13 trials) and "Diagnostic Test" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Cardiovascular Magnetic Resonance" (4 trials), "Echocardiography" (3 trials), "Macitentan" (3 trials) and "TAXUS Liberté-SR" (3 trials). Other intervention names were less common.

The vast majority of trials in "National Heart Centre Singapore" are 113 trials for "All" genders.

Currently, there are 33 active trials in "National Heart Centre Singapore". 1 are not yet recruiting, 25 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 54 completed trials in National Heart Centre Singapore, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in National Heart Centre Singapore, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 19 trials that are defined as “Not Applicable".